We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Cutera Inc (CUTR) USD

Sell:$2.39 Buy:$2.40 Change: $0.25 (9.28%)
Market closed |  Prices as at close on 23 February 2024 | Switch to live prices |
Change: $0.25 (9.28%)
Market closed |  Prices as at close on 23 February 2024 | Switch to live prices |
Change: $0.25 (9.28%)
Market closed |  Prices as at close on 23 February 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Cutera, Inc. is a provider of aesthetic and dermatology solutions for practitioners. The Company develops, manufactures, distributes, and markets energy-based product platforms for use by physicians and other practitioners, enabling them to offer aesthetic treatments to their customers. The Company offers easy-to-use products based on the product platforms, such as enlighten, enlighten SR, excel HR, excel V, excel V+, truSculpt iD, truSculpt flex, Secret PRO, Secret RF, and xeo, each of which enables physicians and other practitioners to perform aesthetic procedures, including treatment for body contouring, skin resurfacing and revitalization, tattoo removal, removal of benign pigmented lesions, vascular conditions, hair removal, and toenail fungus. Its platforms allow for the delivery of laser light and/or RF energy for aesthetic applications from a single system. It also offers products, such as ProWave 770, AcuTip 500, Titan XL, LimeLight, Pearl, Pearl Fractional and ProWave LX.

Contact details

3240 Bayshore Blvd
United States
+1 (415) 6575500

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$54.05 million
Shares in issue:
19.94 million
Health Care Equipment
United States
US dollar
NASDAQ Comb. Composite

Key personnel

  • Taylor Harris
    President, Chief Executive Officer, Director
  • Stuart Drummond
    Interim Chief Financial Officer
  • Jeffrey Jones
    Chief Operating Officer
  • Michael Karavitis
    Chief Technology Officer
  • Stephana Patton
    Chief Legal Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.